CLATAZEV Trademark

Trademark Overview

On Monday, March 25, 2013, a trademark application was filed for CLATAZEV with the United States Patent and Trademark Office. The USPTO has given the CLATAZEV trademark a serial number of 85885429. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2017. This trademark is owned by Bristol-Myers Squibb Company. The CLATAZEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
clatazev

General Information

Serial Number85885429
Word MarkCLATAZEV
Filing DateMonday, March 25, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 28, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, March 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 17, 2016EXTENSION 5 GRANTED
Thursday, August 11, 2016EXTENSION 5 FILED
Thursday, August 11, 2016TEAS EXTENSION RECEIVED
Thursday, February 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 17, 2016EXTENSION 4 GRANTED
Monday, February 8, 2016EXTENSION 4 FILED
Monday, February 8, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 3 GRANTED
Tuesday, August 11, 2015EXTENSION 3 FILED
Tuesday, August 11, 2015TEAS EXTENSION RECEIVED
Thursday, March 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 25, 2015EXTENSION 2 GRANTED
Wednesday, February 11, 2015EXTENSION 2 FILED
Wednesday, March 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 11, 2015TEAS EXTENSION RECEIVED
Wednesday, August 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 11, 2014EXTENSION 1 GRANTED
Monday, August 11, 2014EXTENSION 1 FILED
Monday, August 11, 2014TEAS EXTENSION RECEIVED
Tuesday, February 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 14, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 13, 2013ASSIGNED TO LIE
Thursday, November 7, 2013ASSIGNED TO LIE
Wednesday, October 23, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 14, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2013NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2013NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2013ASSIGNED TO EXAMINER
Thursday, March 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 28, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

clatazev diseases pharmaceutical human anti preparations disorders organ solid auto immune